Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 15
2008 42
2009 45
2010 63
2011 92
2012 85
2013 94
2014 116
2015 111
2016 104
2017 107
2018 110
2019 127
2020 124
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

1,112 results
Results by year
Filters applied: . Clear all
Page 1
Microbial genes and pathways in inflammatory bowel disease.
Schirmer M, Garner A, Vlamakis H, Xavier RJ. Schirmer M, et al. Nat Rev Microbiol. 2019 Aug;17(8):497-511. doi: 10.1038/s41579-019-0213-6. Nat Rev Microbiol. 2019. PMID: 31249397 Free PMC article. Review.
Perturbations in the intestinal microbiome are implicated in inflammatory bowel disease (IBD). Studies of treatment-naive patients have identified microbial taxa associated with disease course and treatment efficacy. To gain a mechanistic understanding …
Perturbations in the intestinal microbiome are implicated in inflammatory bowel disease (IBD). Studies of treatment-nai …
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.
Lee JY, Hall JA, Kroehling L, Wu L, Najar T, Nguyen HH, Lin WY, Yeung ST, Silva HM, Li D, Hine A, Loke P, Hudesman D, Martin JC, Kenigsberg E, Merad M, Khanna KM, Littman DR. Lee JY, et al. Cell. 2020 Jan 9;180(1):79-91.e16. doi: 10.1016/j.cell.2019.11.026. Epub 2019 Dec 19. Cell. 2020. PMID: 31866067 Free PMC article.
Here, we show that SAAs additionally direct a pathogenic pro-inflammatory Th17 cell differentiation program, acting directly on T cells in collaboration with STAT3-activating cytokines. Using loss- and gain-of-function mouse models, we show that SAA1, SAA2, a …
Here, we show that SAAs additionally direct a pathogenic pro-inflammatory Th17 cell differentiation program, acting directly o …
Innate and adaptive immunity in inflammatory bowel disease.
Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Geremia A, et al. Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15. Autoimmun Rev. 2014. PMID: 23774107 Review.
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). ...On the other hand, besides T helper cell type (Th)1 and Th2 immune responses, other subsets of T cells, namely Th17 and regulatory T (Treg)
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). ...On the other hand
Resveratrol and inflammatory bowel disease: the evidence so far.
Nunes S, Danesi F, Del Rio D, Silva P. Nunes S, et al. Nutr Res Rev. 2018 Jun;31(1):85-97. doi: 10.1017/S095442241700021X. Epub 2017 Dec 1. Nutr Res Rev. 2018. PMID: 29191255 Review.
Despite the fact that inflammatory bowel disease (IBD) has still no recognised therapy, treatments which have proven at least mildly successful in improving IBD symptoms include anti-inflammatory drugs and monoclonal antibodies targeting pro-inflamm
Despite the fact that inflammatory bowel disease (IBD) has still no recognised therapy, treatments which have proven at …
Th17 plasticity and its relevance to inflammatory bowel disease.
Ueno A, Jeffery L, Kobayashi T, Hibi T, Ghosh S, Jijon H. Ueno A, et al. J Autoimmun. 2018 Feb;87:38-49. doi: 10.1016/j.jaut.2017.12.004. Epub 2017 Dec 28. J Autoimmun. 2018. PMID: 29290521 Review.
This requires a delicate balance between regulatory and effector T cells; loss of this balance is thought to lead to the development of Crohn's disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel disease (IBD …
This requires a delicate balance between regulatory and effector T cells; loss of this balance is thought to lead to the development …
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORgammat(+) Regulatory T Cells and Exacerbate Colitis in Mice.
Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ. Britton GJ, et al. Immunity. 2019 Jan 15;50(1):212-224.e4. doi: 10.1016/j.immuni.2018.12.015. Immunity. 2019. PMID: 30650377 Free PMC article.
Microbiota are thought to influence the development and progression of inflammatory bowel disease (IBD), but determining generalizable effects of microbiota on IBD etiology requires larger-scale functional analyses. ...The proportions of Th17 and RORga …
Microbiota are thought to influence the development and progression of inflammatory bowel disease (IBD), but determinin …
Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K, Beikler T. Bunte K, et al. Int J Mol Sci. 2019 Jul 10;20(14):3394. doi: 10.3390/ijms20143394. Int J Mol Sci. 2019. PMID: 31295952 Free PMC article. Review.
Any dysregulation of this interaction can result in chronic inflammation and autoimmunity and is thought to be a major underlying cause in the initiation and progression of highly prevalent immune-mediated inflammatory diseases (IMIDs) such as psoriasis, rheumatoid …
Any dysregulation of this interaction can result in chronic inflammation and autoimmunity and is thought to be a major underlying cause in t …
Immunopathology of inflammatory bowel disease.
Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Wallace KL, et al. World J Gastroenterol. 2014 Jan 7;20(1):6-21. doi: 10.3748/wjg.v20.i1.6. World J Gastroenterol. 2014. PMID: 24415853 Free PMC article. Review.
Inflammatory bowel disease (IBD) results from a complex series of interactions between susceptibility genes, the environment, and the immune system. ...Various components of the mucosal immune system are implicated in the pathogenesis of IBD and include intes
Inflammatory bowel disease (IBD) results from a complex series of interactions between susceptibility genes, the enviro
Inflammatory bowel disease: cause and immunobiology.
Baumgart DC, Carding SR. Baumgart DC, et al. Lancet. 2007 May 12;369(9573):1627-40. doi: 10.1016/S0140-6736(07)60750-8. Lancet. 2007. PMID: 17499605 Review.
Crohn's disease and ulcerative colitis are idiopathic inflammatory bowel disorders. ...We pay special attention to pattern-recognition receptors, such as toll-like receptors and nucleotide-binding-oligomerisation-domains (NOD), NOD-like receptors and their mu …
Crohn's disease and ulcerative colitis are idiopathic inflammatory bowel disorders. ...We pay special attention to patt …
IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF. Neurath MF. Cytokine Growth Factor Rev. 2019 Feb;45:1-8. doi: 10.1016/j.cytogfr.2018.12.002. Epub 2018 Dec 12. Cytokine Growth Factor Rev. 2019. PMID: 30563755 Review.
Studies in recent years have identified a pivotal role of the cytokine IL-23 in the pathogenesis of inflammatory bowel diseases (IBD: Crohns disease, ulcerative colitis) and colitis-associated colon cancer. ...This finding was associated with reduced a …
Studies in recent years have identified a pivotal role of the cytokine IL-23 in the pathogenesis of inflammatory bowel dise
1,112 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page